FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

View source ↗

Summary

FDA approves Mimrylo (rusfertide) as the first drug of its kind for adults with polycythemia vera, a rare blood disorder causing excess red blood cell productio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Mimrylo (rusfertide)

Snippet

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.